These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34170371)

  • 1. Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial.
    Salib M; Girerd S; Girerd N; März W; Scharnagl H; Massy ZA; Leroy C; Duarte K; Holdaas H; Jardine AG; Schmieder RE; Fellström B; López-Andrés N; Rossignol P; Zannad F
    Clin Res Cardiol; 2022 Jun; 111(6):614-626. PubMed ID: 34170371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of Procollagen Type I C-Terminal Pro-Peptide and Galectin-3, Arterial Stiffness Measured By Pulse Wave Velocity, and Cardiovascular Morbidity and Mortality in 44 Patients 2 Years After Kidney Transplantation.
    Salib M; Girerd N; Simon A; Kearney-Schwartz A; Duarte K; Leroy C; Rossignol P; Benetos A; Frimat L; Girerd S
    Ann Transplant; 2023 Apr; 28():e938137. PubMed ID: 37095693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Validation of a Screening Biomarker Approach Combining Amino-Terminal Pro-Brain Natriuretic Peptide With Galectin-3 Predicts Death and Cardiovascular Events in Asymptomatic Hemodialysis Patients.
    Voroneanu L; Siriopol D; Apetrii M; Hogas S; Onofriescu M; Nistor I; Kanbay M; Dumea R; Cusai S; Cianga P; Constantinescu D; Covic A
    Angiology; 2018 May; 69(5):449-455. PubMed ID: 28974104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin.
    López B; González A; Querejeta R; Zubillaga E; Larman M; Díez J
    Eur J Heart Fail; 2015 Apr; 17(4):385-92. PubMed ID: 25684565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent and incremental prognostic value of novel cardiac biomarkers in chronic hemodialysis patients.
    Obokata M; Sunaga H; Ishida H; Ito K; Ogawa T; Ando Y; Kurabayashi M; Negishi K
    Am Heart J; 2016 Sep; 179():29-41. PubMed ID: 27595677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Elevated Plasma Galectin-3 for Renal Adverse Events in Dialysis Patients: A Systematic Review and Meta-Analysis.
    Lu H; Shen J; Sun J; Sun J
    Altern Ther Health Med; 2023 Nov; 29(8):86-91. PubMed ID: 37652423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fibrosis marker galectin-3 and outcome in the general population.
    de Boer RA; van Veldhuisen DJ; Gansevoort RT; Muller Kobold AC; van Gilst WH; Hillege HL; Bakker SJ; van der Harst P
    J Intern Med; 2012 Jul; 272(1):55-64. PubMed ID: 22026577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Sensitive Cardiac Troponin T for Prediction of Cardiovascular Outcomes in Stable Maintenance Hemodialysis Patients: A 3-Year Prospective Study.
    Sun L; Wang Y; Zhang N; Xie X; Ding M; Guo H; Li F; Wang X
    Kidney Blood Press Res; 2021; 46(4):484-494. PubMed ID: 34167109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Galectin-3 levels and all-cause and cardiovascular mortality in maintenance hemodialysis patients: a prospective cohort study.
    Liu S; Wu Q; Zhang S; Wang Z; Liu H; Teng L; Xiao P; Lu Y; Wang X; Dong C; Xiao J; Zhang J
    BMC Nephrol; 2022 Jan; 23(1):5. PubMed ID: 34979958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Value of Collagen Biomarkers in Advanced Chronic Kidney Disease Patients.
    Ureche C; Dodi G; Șerban AM; Covic AS; Voroneanu L; Hogaș S; Sascău RA; Stătescu C; Covic A
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of carboxy-terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy - A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy.
    Raafs AG; Verdonschot JAJ; Henkens MTHM; Adriaans BP; Wang P; Derks K; Abdul Hamid MA; Knackstedt C; van Empel VPM; Díez J; Brunner-La Rocca HP; Brunner HG; González A; Bekkers SCAM; Heymans SRB; Hazebroek MR
    Eur J Heart Fail; 2021 Jun; 23(6):933-944. PubMed ID: 33928704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial.
    Lopez-Andrès N; Rossignol P; Iraqi W; Fay R; Nuée J; Ghio S; Cleland JG; Zannad F; Lacolley P
    Eur J Heart Fail; 2012 Jan; 14(1):74-81. PubMed ID: 22089058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-3 is independently associated with cardiovascular mortality in community-dwelling older adults without known cardiovascular disease: The Rancho Bernardo Study.
    Daniels LB; Clopton P; Laughlin GA; Maisel AS; Barrett-Connor E
    Am Heart J; 2014 May; 167(5):674-82.e1. PubMed ID: 24766977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial.
    Cleland JGF; Ferreira JP; Mariottoni B; Pellicori P; Cuthbert J; Verdonschot JAJ; Petutschnigg J; Ahmed FZ; Cosmi F; Brunner La Rocca HP; Mamas MA; Clark AL; Edelmann F; Pieske B; Khan J; McDonald K; Rouet P; Staessen JA; Mujaj B; González A; Diez J; Hazebroek M; Heymans S; Latini R; Grojean S; Pizard A; Girerd N; Rossignol P; Collier TJ; Zannad F;
    Eur Heart J; 2021 Feb; 42(6):684-696. PubMed ID: 33215209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
    Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
    Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Value for Galectin 3 and Cardiotrophin 1 in Hemodialysis Patients.
    Hogas S; Schiller A; Voroneanu L; Constantinescu D; Timar R; Cianga P; Siriopol D; Bob F; Cianga C; Onofriescu M; Gadalean F; Hogas M; Mihaescu A; Bilha SC; Timar B; Kanbay M; Banach M; Covic A
    Angiology; 2016 Oct; 67(9):854-9. PubMed ID: 26787685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure.
    Ahmad T; Fiuzat M; Neely B; Neely ML; Pencina MJ; Kraus WE; Zannad F; Whellan DJ; Donahue MP; Piña IL; Adams KF; Kitzman DW; O'Connor CM; Felker GM
    JACC Heart Fail; 2014 Jun; 2(3):260-8. PubMed ID: 24952693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Yang C; Qiao S; Song Y; Liu Y; Tang Y; Deng L; Yuan J; Hu F; Yang W
    Cardiovasc Pathol; 2019; 43():107150. PubMed ID: 31639652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connection between Cardiac Fibrosis Biomarkers and Echocardiography Parameters in Advanced Chronic Kidney Disease Patients.
    Ureche C; Dodi G; Covic A; Nedelcu A; Volovăț SR; Sascău RA; Stătescu C; Covic A
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.